威廉亚洲博彩公司 &解读威廉亚洲博彩公司

订阅

MedSci主页 / 所有栏目 / 威廉亚洲博彩公司 &解读威廉亚洲博彩公司

2017 ESGE/ESHRE/WES建议：手术治疗子宫内膜异位症

2017-12-19 欧洲妇科内镜学会 Gynecol Surg. 2017;14(1):27.

手术治疗子宫内膜异位症

2017年12月，欧洲妇科内镜学会(ESGE)，欧洲人类生殖及胚胎学会(ESHRE)以及世界子宫内膜异位症学会(WES)联合发布了子宫内膜异位症手术治疗建议。文章主要介绍子宫内膜瘤手术治疗。进一步的本系列的文章将为深部和腹膜内子宫内膜异位症的手术提供建议。

中文标题：

2017 ESGE/ESHRE/WES建议：手术治疗子宫内膜异位症

英文标题：

Recommendations for the surgicaltreatment of endometriosis—part 1:ovarian endometrioma

发布机构：

欧洲妇科内镜学会

发布日期：

2017-12-19

简要介绍：

2017年12月，欧洲妇科内镜学会(ESGE)，欧洲人类生殖及胚胎学会(ESHRE)以及世界子宫内膜异位症学会(WES)联合发布了子宫内膜异位症手术治疗建议。文章主要介绍子宫内膜瘤手术治疗。进一步的本系列的文章将为深部和腹膜内子宫内膜异位症的手术提供建议。

 

拓展威廉亚洲博彩公司 ：与子宫内膜异位相关威廉亚洲博彩公司 ：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2017 ESGE/ESHRE/WES建议：手术治疗子宫内膜异位症)] GetToolGuiderByIdResponse(projectId=1, id=23f881c001539630, title=2017 ESGE/ESHRE/WES建议：手术治疗子宫内膜异位症, enTitle=Recommendations for the surgicaltreatment of endometriosis—part 1:ovarian endometrioma, guiderFrom=Gynecol Surg. 2017;14(1):27., authorId=null, author=, summary=2017年12月，欧洲妇科内镜学会(ESGE)，欧洲人类生殖及胚胎学会(ESHRE)以及世界子宫内膜异位症学会(WES)联合发布了子宫内膜异位症手术治疗建议。文章主要介绍子宫内膜瘤手术治疗。进一步的本系列的文章将为深部和腹膜内子宫内膜异位症的手术提供建议。 , cover=, journalId=null, articlesId=null, associationId=1022, associationName=欧洲妇科内镜学会, associationIntro=null, copyright=0, guiderPublishedTime=Tue Dec 19 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>2017年12月，欧洲妇科内镜学会(ESGE)，欧洲人类生殖及胚胎学会(ESHRE)以及世界子宫内膜异位症学会(WES)联合发布了子宫内膜异位症手术治疗建议。文章主要介绍子宫内膜瘤手术治疗。进一步的本系列的文章将为深部和腹膜内子宫内膜异位症的手术提供建议。 </P> <P> </P>拓展威廉亚洲博彩公司 ：<strong>与<font color=red>子宫内膜异位</font>相关威廉亚洲博彩公司 ：</strong><br><ul><li><a href="//www.nyrain.com/guideline/show_article.do?id=3221b1c00138a535" title="【精品威廉亚洲博彩公司 】女神节来啦，健康是刚需！子宫内膜异位症诊治威廉亚洲博彩公司 2015（附解读视频哦）" target=_blank>【精品威廉亚洲博彩公司 】女神节来啦，健康是刚需！子宫内膜异位症诊治威廉亚洲博彩公司 2015（附解读视频哦）</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=78b511c0013a08e2" title="2016 WES共识：子宫内膜异位症的分类" target=_blank>2016 WES共识：子宫内膜异位症的分类</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=15f8e1c0011699c1" title="子宫内膜异位症诊治威廉亚洲博彩公司 2015" target=_blank>子宫内膜异位症诊治威廉亚洲博彩公司 2015</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=d1ef11c0010a1230" title="2014 欧洲人类生殖及胚胎学会（ESHRE）威廉亚洲博彩公司 ：子宫内膜异位症的治疗" target=_blank>2014 欧洲人类生殖及胚胎学会（ESHRE）威廉亚洲博彩公司 ：子宫内膜异位症的治疗</a></li> <li><a href="//www.nyrain.com/guideline/show_article.do?id=3bfb21c000e9077a" title="2010 EMAS立场声明：既往患有子宫内膜异位症女性更年期的管理" target=_blank>2010 EMAS立场声明：既往患有子宫内膜异位症女性更年期的管理</a></li> 更多信息请点击：<a href="//www.nyrain.com/guideline/list.do?q=%E5%AD%90%E5%AE%AB%E5%86%85%E8%86%9C%E5%BC%82%E4%BD%8D" target=_blank>有关子宫内膜异位更多威廉亚洲博彩公司 </a></ul>, tagList=[TagDto(tagId=3327, tagName=手术治疗), TagDto(tagId=502, tagName=子宫内膜异位症)], categoryList=[CategoryDto(categoryId=85, categoryName=威廉亚洲博彩公司 &解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5342, appHits=276, showAppHits=0, pcHits=3504, showPcHits=2250, likes=102, shares=9, comments=7, approvalStatus=1, publishedTime=Fri Jan 05 00:36:24 CST 2018, publishedTimeString=2017-12-19, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Jan 05 00:36:24 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 21:23:48 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 ESGE/ESHRE/WES建议：手术治疗子宫内膜异位症)])
2017 ESGE/ESHRE/WES建议：手术治疗子宫内膜异位症
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=954758, encodeId=a358954e581d, content=已看，还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:06:56 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922482, encodeId=d25992248227, content=实用的文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2b25458410, createdName=nina, createdTime=Wed Feb 03 16:00:12 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892705, encodeId=8493892e055a, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7115145770, createdName=14686d88m59暂无昵称, createdTime=Sat Oct 17 20:33:51 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275630, encodeId=85482e563041, content=学习了.涨知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Jan 05 08:08:49 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275617, encodeId=a6a92e56172c, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Jan 05 08:00:27 CST 2018, time=2018-01-05, status=1, ipAttribution=)]
    2021-04-07 ms6000001015893838

    已看，还可以。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=954758, encodeId=a358954e581d, content=已看，还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:06:56 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922482, encodeId=d25992248227, content=实用的文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2b25458410, createdName=nina, createdTime=Wed Feb 03 16:00:12 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892705, encodeId=8493892e055a, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7115145770, createdName=14686d88m59暂无昵称, createdTime=Sat Oct 17 20:33:51 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275630, encodeId=85482e563041, content=学习了.涨知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Jan 05 08:08:49 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275617, encodeId=a6a92e56172c, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Jan 05 08:00:27 CST 2018, time=2018-01-05, status=1, ipAttribution=)]
    2021-02-03 nina

    实用的文章

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=954758, encodeId=a358954e581d, content=已看，还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:06:56 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922482, encodeId=d25992248227, content=实用的文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2b25458410, createdName=nina, createdTime=Wed Feb 03 16:00:12 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892705, encodeId=8493892e055a, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7115145770, createdName=14686d88m59暂无昵称, createdTime=Sat Oct 17 20:33:51 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275630, encodeId=85482e563041, content=学习了.涨知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Jan 05 08:08:49 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275617, encodeId=a6a92e56172c, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Jan 05 08:00:27 CST 2018, time=2018-01-05, status=1, ipAttribution=)]
    2020-10-17 14686d88m59暂无昵称

    实用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=954758, encodeId=a358954e581d, content=已看，还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:06:56 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922482, encodeId=d25992248227, content=实用的文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2b25458410, createdName=nina, createdTime=Wed Feb 03 16:00:12 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892705, encodeId=8493892e055a, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7115145770, createdName=14686d88m59暂无昵称, createdTime=Sat Oct 17 20:33:51 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275630, encodeId=85482e563041, content=学习了.涨知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Jan 05 08:08:49 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275617, encodeId=a6a92e56172c, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Jan 05 08:00:27 CST 2018, time=2018-01-05, status=1, ipAttribution=)]
    2018-01-05 1ddf0692m34(暂无匿称)

    学习了.涨知识

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=954758, encodeId=a358954e581d, content=已看，还可以。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 15:06:56 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922482, encodeId=d25992248227, content=实用的文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2b25458410, createdName=nina, createdTime=Wed Feb 03 16:00:12 CST 2021, time=2021-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892705, encodeId=8493892e055a, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7115145770, createdName=14686d88m59暂无昵称, createdTime=Sat Oct 17 20:33:51 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275630, encodeId=85482e563041, content=学习了.涨知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Jan 05 08:08:49 CST 2018, time=2018-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275617, encodeId=a6a92e56172c, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Fri Jan 05 08:00:27 CST 2018, time=2018-01-05, status=1, ipAttribution=)]
    2018-01-05 Y—xianghai

    学习了新知识

    0

相关威廉亚洲博彩公司

2017 最佳实践威廉亚洲博彩公司 ：手术治疗早发型脊柱侧凸手术部位感染预防

国外骨科相关专家小组（统称） · 2017-10-23

《2017年美国东部创伤外科学会胰腺坏死手术治疗实践管理威廉亚洲博彩公司 》摘译

暂未更新 · 2017-10-20

2017 KSTHNS威廉亚洲博彩公司 ：喉癌的手术治疗

韩国甲状腺头颈部外科学会(KSTHNS,Korean Society of Thyroid-Head and Neck Surgery) · 2017-01-03

2017 ECCO/ESCP共识：克罗恩病的手术治疗

暂未更新 · 2017-05-11

2017 ACPGBI共识：克罗恩病肛周瘘管的手术治疗

大不列颠及爱尔兰肛肠协会(ACPGBI,Association of Coloproctology of Great Britain and Ireland) · 2017-04-07

2017 ENETS共识威廉亚洲博彩公司 ：小肠和胰腺神经内分泌瘤的手术治疗

欧洲神经内分泌肿瘤学会(ENETS,European Neuroendocrine Tumor Society) · 2017-02-28